Eric D. Shaff Seres Therapeutics, Inc. (MCRB) insider trading activity
Eric D. Shaff is CEO and President of Seres Therapeutics, Inc.. Currently has a direct ownership of 165,082 shares of MCRB, which is worth approximately $135,367. The most recent transaction as insider was on Oct 28, 2024, when has been sold 8,748 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $6,036. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
165K
17.33%
3M change
42.78%
12M change
Total Value Held
$135,367
Eric D. Shaff Transaction History
Also insider at
EDS
Eric D. Shaff
CEO and President
Cambridge, MA